2m 2m 2m 2m 2m 2m 2m
LONGEVERON-A (LGVN)
NASDAQ
$3.24-$0.06 (-1.76%)
Price as of Nov 12, 2026 9:25 AM EST- $10.0MMarket Cap
- -53.36%1-Year Change
- BiotechnologyIndustry
LONGEVERON-A (LGVN)
$3.24-$0.06 (-1.76%)
LGVN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.30 | ||
Change | +$0.46 (+16.20%) | ||
Open | $2.92 | ||
High | $3.30 | ||
Low | $2.91 | ||
Previous Close | $2.84 | ||
Volume | 132,317 | ||
30-Day Average Volume | 103,756 | ||
1-Week Change | 85.39% | ||
1-Month Change | 33.06% | ||
1-Year Change | -53.36% | ||
3-Year Change | -98.19% | ||
5-Year Change | -99.05% | ||
Fundamentals | |||
Shares Outstanding | 3.0M | ||
Total Assets | $15.5M | ||
Market Cap | $10.0M | ||
Enterprise Value | -$34,117.00 | ||
Period: QTR TTM FY | |||
Revenue | $287,000.00 | ||
Net Income | -$6.1M | ||
Free Cash Flow | -$5.8M | ||
EBIT | -$6.1M | ||
EBITDA | -$5.9M | ||
Net Working Capital | $7.0M | ||
EPS | -$1.90 | ||
Enterprise Value/EBITDA | 0 | ||
Enterprise Value/Revenue | -0 | ||
P/B | 1 | ||
P/E | -2 | ||
PEG | N/A | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 08/27/2026 | ||
Earnings & Revenue